Improved electronic reporting of suspected adverse reactions for better health protection

The European Medicines Agency (EMA) has published a change management plan to provide stakeholders with comprehensive information to be ready for improvements to the EudraVigilance.

The plan details the technical changes as well as business process changes in relation to reporting, managing and analysing individual case safety reports (ICSRs) from medicines in clinical use and from clinical trials.

Original source


Register for receiving PharmaAround news, register for PharmAround events.
Continue registration